1286502

Biocon Generics Inc. — FEI 3014086465

Inspection Details

Classification
Voluntary Action Indicated (VAI) (VAI)
End Date
October 10, 2025
Fiscal Year
2026
Product Type
Drugs
Project Area
Drug Quality Assurance
Location
Cranbury, NJ (United States)

Citations

IDCFRDescription
434021 CFR 211.142Written warehousing procedures established/followed